Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500112358Phase 4Not yet recruiting
Phase 4, randomised trial of ciprofol in breast lesion (2 arms), sponsored by The Affiliated Hospital of Guangdong Medical University. Primary endpoint: Sedation success rate. Planned start Nov 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500112358.